Can a new gel calm psoriasis Flare-Ups?
NCT ID NCT06620692
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests whether a topical gel called GM-XANTHO can reduce the severity of psoriasis, a chronic skin condition that causes red, scaly patches. About 65 adults with plaque psoriasis will apply the gel or a placebo daily for 28 days. Researchers will measure changes in skin area affected, symptom severity, and quality of life, while also monitoring safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GM-XANTHO [GM-XAN003] topical gel
- What this could lead to
- If successful, this could lead to a new topical treatment option for psoriasis that reduces skin symptoms and improves quality of life.
- What could go wrong
- This is an early-phase trial with a small number of participants, so results may not hold up in larger studies. The treatment may cause skin irritation or other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Once-Daily cream tame psoriasis in toddlers?
- Can a switch to guselkumab clear stubborn psoriasis?
- Can a new biologic clear stubborn psoriasis?
- Diet and exercise may tame psoriasis in kids — a trial puts it to the test
- Ancient herbal mix put to the test against psoriasis
- Can a new daily pill quiet the immune attack behind psoriasis?